Affordable Access

Publisher Website

CD 133+and CXCR4+colon cancer cells as a marker for lymph node metastasis

Authors
Journal
Journal of Surgical Research
0022-4804
Publisher
Elsevier
Volume
185
Issue
1
Identifiers
DOI: 10.1016/j.jss.2013.05.049
Keywords
  • Cd133
  • Cxcr4
  • Co-Tic
  • Cxcl12
Disciplines
  • Medicine

Abstract

Abstract Introduction Colorectal cancer (CRC) stem cells or tumor-initiating cells (Co-TIC) are implicated in both cancer recurrence and extranodal metastasis. CD133 and CXCR4 are specific cell surface markers that are indicators of Co-TIC. The presence of lymph node (LN) metastases is one of the strongest negative prognostic factors for CRC patients. We examined the relationship between the Co-TIC markers CD133 and CXCR4 and LN involvement in CRC. Methods CRC cells were isolated via enzymatic digestion. CD133+, CXCR4+, and double-positive CRC cells were detected by fluorescence-activated cell sorting analysis. The percentages of CD133+, CXCR4+, and double-positive cells were identified and correlated to the number and percentage of positive LN on staging. Results Twenty-seven samples underwent fluorescence-activated cell sorting analysis. The mean percentage of CD133+ cells was 3.94% (range 0.15%–19.06%). The mean percentage of CXCR4+ cells was 6.15% (range 0%–27.11%). The mean percentage of CD133+CXCR4+ cells was 0.45% (range 0%–2.08%). Thirteen patients had LN metastasis: 8 N1 disease and 5 N2 disease. The correlation coefficients between the percentage of Co-TIC marker–positive cells and percentage of positive LN were r = 0.58 (P = 0.0016) for CD133+ cells, r = 0.36 (P = 0.5868) for CXCR4+ cells, and r = 0.56 (P = 0.0022) for double-positive cells. Discussion Our results show CD133+ and CD133+CXCR4+ cancer cells correlate with the presence of LN metastasis in CRC. Further studies will examine whether these markers can give consistent prognostic information and may help to develop novel diagnostic and therapeutic options.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Expression of cancer stem cell markers ALDH1, CD44...

on Pathology international February 2012

Relationship of CD44+CD24-/low breast cancer stem...

on Journal of Translational Medic... Sep 19, 2012

Relationship of CD44+CD24-/low breast cancer stem...

on Journal of Translational Medic... Jan 01, 2012
More articles like this..